ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

VALFIX Medical Receives its Fourth Consecutive Grant from the Israel Innovation Authority

By: PRLog

TEL AVIV, Israel - June 6, 2022 - PRLog -- VALFIX Medical Inc. announces today that it has secured its fourth grant from the Israel Innovation Authority. This is the fourth consecutive year that VALFIX Medical is receiving an R&D grant from the Israel Innovation Authority and is the largest amount the company has ever been granted.

This grant is complementary to the company's current Series A investment round. "This grant is a part of our efforts to raise funds for our current series A investment round and secures a significant capital of this round," states Eli Bar, VALFIX Medical CEO. "We know that receiving this grant for the fourth consecutive time sets us apart and validates our ongoing success and accomplishments in our development. We look forward to closing this round and continuing to advance our technology."

This Series A investment round will fund team expansion, production scale up, V&V testing, and first in human clinical study.

VALFIX Medical has received a total of more than 9 million NIS (2.6 million USD) in grants from the Israel Innovation Authority since 2017. Approval for grants from the Israel Innovation Authority requires due diligence and an extensive review of the company's ongoing achievements, progression and execution, assets, and plans.

About VALFIX Medical:

VALFIX Medical has designed an innovative transcatheter system to convert open heart valve surgery to a transcatheter procedure bringing new hope to FMR patients suffering from heart failure.

To learn more about VALFIX Medical visit our website at www.valfixmed.com or contact us directly at info@valfixmed.com

About the Israel Innovation Authority

The Israel Innovation Authority is an independent publicly funded agency, created to provide a variety of practical tools and funding platforms for early-stage entrepreneurs. https://innovationisrael.org.il/en/

Media Contact
Devra Igra
devra.igra@valfixmed.com
+972733744805

Photos: (Click photo to enlarge)

VALFIX Medical Logo VALFIX Medical innovative transcatheter system

Read Full Story - VALFIX Medical Receives its Fourth Consecutive Grant from the Israel Innovation Authority | More news from this source

Press release distribution by PRLog

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.